Literature DB >> 33802616

Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides.

P Marcos1, R Coveñas2.   

Abstract

Obesity/overweight are important health problems due to metabolic complications. Dysregulation of peptides exerting orexigenic/anorexigenic effects must be investigated in-depth to understand the mechanisms involved in feeding behaviour. One of the most important and studied orexigenic peptides is galanin (GAL). The aim of this review is to update the mechanisms of action and physiological roles played by the GAL family of peptides (GAL, GAL-like peptide, GAL message-associated peptide, alarin) in the control of food intake and to review the involvement of these peptides in metabolic diseases and food intake disorders in experimental animal models and humans. The interaction between GAL and NPY in feeding and energy metabolism, the relationships between GAL and other substances involved in food intake mechanisms, the potential pharmacological strategies to treat food intake disorders and obesity and the possible clinical applications will be mentioned and discussed. Some research lines are suggested to be developed in the future, such as studies focused on GAL receptor/neuropeptide Y Y1 receptor interactions in hypothalamic and extra-hypothalamic nuclei and sexual differences regarding the expression of GAL in feeding behaviour. It is also important to study the possible GAL resistance in obese individuals to better understand the molecular mechanisms by which GAL regulates insulin/glucose metabolism. GAL does not exert a pivotal role in weight regulation and food intake, but this role is crucial in fat intake and also exerts an important action by regulating the activity of other key compounds under conditions of stress/altered diet.

Entities:  

Keywords:  GAL message-associated peptide; GAL receptor; GAL-like peptide; alarin; celastrol; daidzein; obesity; orexigenic peptides; spexin

Mesh:

Substances:

Year:  2021        PMID: 33802616      PMCID: PMC7961366          DOI: 10.3390/ijms22052544

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  95 in total

1.  An assembly of galanin-galanin receptor signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Chinmayi Raj; Deepshika Pullimamidi; Jayshree Advani; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

2.  Interactive effect of galanin-like peptide (GALP) and spontaneous exercise on energy metabolism.

Authors:  Kazuo Ito; Haruaki Kageyama; Satoshi Hirako; Lihua Wang; Fumiko Takenoya; Tetsuro Ogawa; Seiji Shioda
Journal:  Peptides       Date:  2013-09-18       Impact factor: 3.750

3.  Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity.

Authors:  Nadine Schäuble; Kathrin Reichwald; Wolfgang Grassl; Helen Bechstein; Hans-Christian Müller; André Scherag; Frank Geller; Michael Utting; Wolfgang Siegfried; Hanspeter Goldschmidt; John Blundell; Clare Lawton; Rahul Alam; Stephen Whybrow; James Stubbs; Matthias Platzer; Johannes Hebebrand; Anke Hinney
Journal:  J Nutr       Date:  2005-06       Impact factor: 4.798

4.  Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice.

Authors:  Ahreum Kim; Taesun Park
Journal:  Mol Nutr Food Res       Date:  2010-09       Impact factor: 5.914

Review 5.  Sex differences in the physiology of eating.

Authors:  Lori Asarian; Nori Geary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-31       Impact factor: 3.619

6.  Positive correlation of galanin with insulin resistance and triglyceride levels in obese zzm321990children

Authors:  Sezer Acar; Ahu Paketçi; Tuncay Küme; Korcan Demir; Özlem Gürsoy Çalan; Ece Böber; Ayhan Abacı
Journal:  Turk J Med Sci       Date:  2018-06-14       Impact factor: 0.973

Review 7.  Oleoylethanolamide: A fat ally in the fight against obesity.

Authors:  Jacob D Brown; Elnaz Karimian Azari; Julio E Ayala
Journal:  Physiol Behav       Date:  2017-02-27

8.  PVN galanin increases fat storage and promotes obesity by causing muscle to utilize carbohydrate more than fat.

Authors:  R Yun; J T Dourmashkin; J Hill; E C Gayles; S K Fried; S F Leibowitz
Journal:  Peptides       Date:  2005-11       Impact factor: 3.750

9.  Blunted leptin sensitivity during hedonic overeating can be reinstated by activating galanin 2 receptors (Gal2R) in the lateral hypothalamus.

Authors:  Este Leidmaa; Mary Gazea; Alexandre V Patchev; Anna Pissioti; Nils Christian Gassen; Mayumi Kimura; Zsolt Liposits; Imre Kallo; Osborne F X Almeida
Journal:  Acta Physiol (Oxf)       Date:  2019-07-31       Impact factor: 6.311

10.  A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling.

Authors:  T M Hsu; E E Noble; C M Liu; A M Cortella; V R Konanur; A N Suarez; D J Reiner; J D Hahn; M R Hayes; S E Kanoski
Journal:  Mol Psychiatry       Date:  2017-05-02       Impact factor: 15.992

View more
  5 in total

1.  The Pivotal Role of Neuropeptide Crosstalk from Ventromedial-PACAP to Dorsomedial-Galanin in the Appetite Regulation in the Mouse Hypothalamus.

Authors:  Yuki Kambe; Thanh Trung Nguyen; Toshiharu Yasaka; Thu Thi Nguyen; Yoshimune Sameshima; Kohei Hashiguchi; Norihito Shintani; Hitoshi Hashimoto; Takashi Kurihara; Atsuro Miyata
Journal:  Mol Neurobiol       Date:  2022-10-17       Impact factor: 5.682

Review 2.  Insects as a New Complex Model in Hormonal Basis of Obesity.

Authors:  Karolina Walkowiak-Nowicka; Szymon Chowański; Arkadiusz Urbański; Paweł Marciniak
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

Review 3.  Leptin-A Potential Bridge between Fat Metabolism and the Brain's Vulnerability to Neuropsychiatric Disorders: A Systematic Review.

Authors:  Gilmara Gomes de Assis; Eugenia Murawska-Ciałowicz
Journal:  J Clin Med       Date:  2021-12-06       Impact factor: 4.241

Review 4.  The Galaninergic System: A Target for Cancer Treatment.

Authors:  Manuel Lisardo Sánchez; Rafael Coveñas
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

Review 5.  Celastrol: A Promising Agent Fighting against Cardiovascular Diseases.

Authors:  Zhexi Li; Jingyi Zhang; Xulei Duan; Guoan Zhao; Min Zhang
Journal:  Antioxidants (Basel)       Date:  2022-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.